Juan M. Gimenez

Radiology

1514 Jefferson Hwy
New Orleans, LA 70121

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Baseline Tumor-Specific Prognosis in Early-Stage Hepatocellular Carcinoma: Time-Dependent Role of Biomarker Profile and Modified ALBI Grade.

Baseline Tumor-Specific Prognosis in Early-Stage Hepatocellular Carcinoma: Time-Dependent Role of Biomarker Profile and Modified ALBI Grade.

Journal: Cancers

Published: May 28, 2026

Consortium on Bridging Radiation Segmentectomy (COBRAS): A Multicenter Study of Complete Pathologic Necrosis in Hepatocellular Carcinoma.

Consortium on Bridging Radiation Segmentectomy (COBRAS): A Multicenter Study of Complete Pathologic Necrosis in Hepatocellular Carcinoma.

Journal: Radiology

Published: May 05, 2026

Single-system outcomes after adopting yttrium-90 radioembolization with personalized dosimetry as the primary treatment approach for unresectable, solitary hepatocellular carcinoma.

Single-system outcomes after adopting yttrium-90 radioembolization with personalized dosimetry as the primary treatment approach for unresectable, solitary hepatocellular carcinoma.

Journal: ESMO gastrointestinal oncology

Published: April 17, 2026

Ablative Radioembolization Dosing Thresholds for Glass Microspheres Predictive of Complete Imaging Response and Survival in Patients with Hepatocellular Carcinomas Larger than 4 cm: A Multi-institution Retrospective Analysis.

Ablative Radioembolization Dosing Thresholds for Glass Microspheres Predictive of Complete Imaging Response and Survival in Patients with Hepatocellular Carcinomas Larger than 4 cm: A Multi-institution Retrospective Analysis.

Journal: Journal of vascular and interventional radiology : JVIR

Published: March 26, 2026

Radioembolization (90Y) achieves higher response rates and reduces progression risk compared with DEB-TACE in hepatocellular carcinoma.

Radioembolization (90Y) achieves higher response rates and reduces progression risk compared with DEB-TACE in hepatocellular carcinoma.

Journal: Hepatology communications

Published: December 01, 2025

Understanding Current Trends and Advances in Transarterial Radioembolization Dosimetry.

Understanding Current Trends and Advances in Transarterial Radioembolization Dosimetry.

Journal: Diagnostics (Basel, Switzerland)

Published: November 03, 2025

Sustained AFP-L3 or DCP expression is associated with progression risk and inferior outcomes in unresectable hepatocellular carcinoma.

Sustained AFP-L3 or DCP expression is associated with progression risk and inferior outcomes in unresectable hepatocellular carcinoma.

Journal: Clinical and experimental medicine

Published: July 24, 2025

Contemporary Clinical Utilization of Radioembolization with Immune Checkpoint Inhibitors as First-Line Treatment in HCC: Real-World Report on Safety and Outcomes.

Contemporary Clinical Utilization of Radioembolization with Immune Checkpoint Inhibitors as First-Line Treatment in HCC: Real-World Report on Safety and Outcomes.

Journal: Cancers

Published: July 22, 2025

The Sphere Conundrum: Author's Reply to Commentary on Voxel-Based Dosimetry with Glass Microspheres.

The Sphere Conundrum: Author's Reply to Commentary on Voxel-Based Dosimetry with Glass Microspheres.

Journal: Journal of vascular and interventional radiology : JVIR

Published: July 27, 2024

Yttrium-90 Induces an Effector Memory Response with Neoantigen Clonotype Expansion: Implications for Immunotherapy.

Yttrium-90 Induces an Effector Memory Response with Neoantigen Clonotype Expansion: Implications for Immunotherapy.

Journal: Cancer research communications

Published: April 19, 2024

Imaging Delay Following Liver-Directed Therapy Increases Progression Risk in Early- to Intermediate-Stage Hepatocellular Carcinoma.

Imaging Delay Following Liver-Directed Therapy Increases Progression Risk in Early- to Intermediate-Stage Hepatocellular Carcinoma.

Journal: Cancers

Published: November 09, 2023

Using Voxel-Based Dosimetry to Evaluate Sphere Concentration and Tumor Dose in Hepatocellular Carcinoma Treated with Yttrium-90 Radiation Segmentectomy with Glass Microspheres.

Using Voxel-Based Dosimetry to Evaluate Sphere Concentration and Tumor Dose in Hepatocellular Carcinoma Treated with Yttrium-90 Radiation Segmentectomy with Glass Microspheres.

Journal: Journal of vascular and interventional radiology : JVIR

Published: August 23, 2023

Showing 1-12 of 22

Last Updated: 09/26/2026